These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 37125596)
1. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer. Hannarici Z; Yılmaz A; Buyukbayram ME; Turhan A; Çağlar AA; Bilici M; Tekin SB Future Oncol; 2023 Feb; 19(4):315-325. PubMed ID: 37125596 [TBL] [Abstract][Full Text] [Related]
2. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096 [TBL] [Abstract][Full Text] [Related]
3. The prognostic importance of glucose-to-lymphocyte ratio and uric acid in metastatic breast cancer patients treated with Cdk 4/6 inhibitors. Yilmaz H; Nigdelioglu B; Aytac A; Turan M; Oktay E; Yersal O; Barutca S Future Oncol; 2022 Sep; 18(27):3043-3053. PubMed ID: 36062468 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: A retrospective study. Bozkurt O; Firat ST; Dogan E; Cosar R; Inanc M; Ozkan M J BUON; 2019; 24(5):1992-1999. PubMed ID: 31786866 [TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients With Metastatic Gastric or Gastroesophageal Junction Cancer Administered Trifluridine/Tipiracil. Hashimoto I; Kano K; Onuma S; Suematsu H; Nagasawa S; Kanematsu K; Furusawa K; Hamaguchi T; Watanabe M; Hayashi K; Furuta M; Inokuchi Y; Machida N; Aoyama T; Yamada T; Rino Y; Ogata T; Oshima T Anticancer Res; 2023 Apr; 43(4):1689-1697. PubMed ID: 36974783 [TBL] [Abstract][Full Text] [Related]
6. Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy. Petrillo A; Laterza MM; Tirino G; Pompella L; Ventriglia J; Pappalardo A; Famiglietti V; Martinelli E; Ciardiello F; Orditura M; Galizia G; De Vita F Future Oncol; 2018 Oct; 14(24):2493-2505. PubMed ID: 29969285 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer. Gou M; Qu T; Wang Z; Yan H; Si Y; Zhang Y; Dai G J Immunol Res; 2021; 2021():2549295. PubMed ID: 34993252 [TBL] [Abstract][Full Text] [Related]
8. Preoperative glucose-to-lymphocyte ratio predicts survival in cancer. Liu L; Zhang BB; Li YZ; Huang WJ; Niu Y; Jia QC; Wang W; Yuan JR; Miao SD; Wang RT; Wang GY Front Endocrinol (Lausanne); 2024; 15():1284152. PubMed ID: 38501103 [TBL] [Abstract][Full Text] [Related]
9. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment. Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer. Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090 [TBL] [Abstract][Full Text] [Related]
11. The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib. Yılmaz A; Şimşek M; Hannarici Z; Büyükbayram ME; Bilici M; Tekin SB Future Oncol; 2021 Nov; 17(33):4545-4559. PubMed ID: 34431372 [No Abstract] [Full Text] [Related]
12. Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. Mirili C; Yılmaz A; Demirkan S; Bilici M; Basol Tekin S Int J Clin Oncol; 2019 Oct; 24(10):1301-1310. PubMed ID: 31073814 [TBL] [Abstract][Full Text] [Related]
13. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Li QQ; Lu ZH; Yang L; Lu M; Zhang XT; Li J; Zhou J; Wang XC; Gong JF; Gao J; Li J; Li Y; Shen L Asian Pac J Cancer Prev; 2014; 15(2):945-50. PubMed ID: 24568523 [TBL] [Abstract][Full Text] [Related]
14. The neutrophil-to-lymphocyte ratio prechemotherapy and postchemotherapy as a prognostic marker in metastatic gastric cancer. Kim H; Ro SM; Yang JH; Jeong JW; Lee JE; Roh SY; Kim IH Korean J Intern Med; 2018 Sep; 33(5):990-999. PubMed ID: 29722249 [TBL] [Abstract][Full Text] [Related]
15. Novel immunological and nutritional-based prognostic index for gastric cancer. Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461 [TBL] [Abstract][Full Text] [Related]
16. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689 [TBL] [Abstract][Full Text] [Related]
17. The relationship between platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 Fluorourasil Regimen: A single institute experience. Dogan M; Eren T; Ozdemir N; Cigirgan CL; Zengin N Saudi J Gastroenterol; 2015; 21(5):320-4. PubMed ID: 26458860 [TBL] [Abstract][Full Text] [Related]
18. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy. Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323 [TBL] [Abstract][Full Text] [Related]
19. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy. Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics. Wang J; Liu Y; Mi X; Shao M; Liu L Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]